Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.
about
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesEffect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and AdolescentsPolyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database.Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison's disease: a case report.Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium.The next big idea.Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia.Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus.Genetics and autoantibodies.Celiac disease and endocrine autoimmune disorders in children: an update.Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations.Cortisol hyporesponsiveness to the low dose ACTH test is a frequent finding in a pediatric population with type 1 diabetes mellitus.[Prevalence of anti-thyroid peroxidase and anti-adrenal 21-hidroxylase in type 1 diabetes patients].Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry.
P2860
Q24675521-AB67387C-2292-4AC9-AA2D-F811E5911D4DQ26741457-7768E64C-20CE-4DDF-8553-F1D531EFD9C9Q34084556-151523DC-ADEF-4DC5-ACE0-5DE63648A2FBQ34217418-9D36E313-9F28-41CC-8CBC-27C7D2DD6935Q35043719-CE34B034-DF10-4C3D-96F5-C22DA7692007Q36134694-B89BC7A6-2E5F-4DDF-88F9-7FEE44A8C1CAQ36913144-89C2F22D-27AA-4795-9CCA-AEA559D58359Q37008682-68C61286-03DC-46C8-A66F-CF6023057404Q37131215-47B5C76D-47A6-454A-97F7-2E5AD7D1EAAFQ37417471-AFB97A40-EEE6-4EEB-B50D-C34B9841FD11Q37643691-6F8A97A2-46A1-4F0E-99CC-089AB2CA4B5BQ38096937-56762A76-8735-48FA-9C60-94AAA6DAA26AQ38161565-94FFA4FC-695F-49C7-BE02-EE37E1480B9FQ39152592-12182D31-F166-4584-ABAD-B3CDAFB257BAQ42435675-DB357408-5415-48EA-BD94-32468E3F3790Q43299782-A3CFF5E8-BD7C-4BE4-9A92-668810C13230Q49715013-E31B5C4C-A309-4F52-B542-2B219EFDADF7
P2860
Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Endocrine and immunogenetic te ...... ase in a high-risk population.
@en
Endocrine and immunogenetic te ...... ase in a high-risk population.
@nl
type
label
Endocrine and immunogenetic te ...... ase in a high-risk population.
@en
Endocrine and immunogenetic te ...... ase in a high-risk population.
@nl
prefLabel
Endocrine and immunogenetic te ...... ase in a high-risk population.
@en
Endocrine and immunogenetic te ...... ase in a high-risk population.
@nl
P2093
P356
P1476
Endocrine and immunogenetic te ...... ase in a high-risk population.
@en
P2093
Corey Hostetler
Dongmei Miao
George S Eisenbarth
Jennifer M Barker
Pamela R Fain
Peter A Gottlieb
P304
P356
10.1210/JC.2004-0874
P407
P577
2004-10-13T00:00:00Z